Life Science REIT plc (LON:LABS - Get Free Report)'s stock price traded up 1.4% during mid-day trading on Thursday . The company traded as high as GBX 43.60 ($0.58) and last traded at GBX 43.60 ($0.58). 350,011 shares changed hands during trading, a decline of 60% from the average session volume of 878,960 shares. The stock had previously closed at GBX 43 ($0.57).
Life Science REIT Trading Down 0.5%
The company has a market cap of £151.24 million, a PE ratio of -3.78 and a beta of 0.08. The business has a fifty day moving average of GBX 43.13 and a 200-day moving average of GBX 39.25.
Life Science REIT (LON:LABS - Get Free Report) last announced its quarterly earnings results on Wednesday, April 16th. The company reported GBX 1.70 ($0.02) earnings per share (EPS) for the quarter. Life Science REIT had a negative return on equity of 14.53% and a negative net margin of 198.99%.
Life Science REIT Company Profile
(
Get Free Report)
Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange.
Featured Stories
Before you consider Life Science REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Life Science REIT wasn't on the list.
While Life Science REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
